Maetzold Derek J's Form 4 filing
Castle Biosciences Inc (CSTL) · filed Sep 16, 2021
- Accession no.
- 0001447362-21-000223
- Filed
- Sep 16, 2021
- Trade date
- Sep 15, 2021
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 9 non-derivative transactions. Open-market sales total $1.12M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Maetzold Derek JCIK 0001239501 | Director, Officer (Pres. & Chief Exec. Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2021 | Common Stock | SSaleDisposed | −958 | $73.30F2 | −$70,221.4 | 325,060 | Direct | |
| Sep 15, 2021 | Common Stock | SSaleDisposed | −8,531 | $74.45F3 | −$635,132.95 | 316,529 | Direct | |
| Sep 15, 2021 | Common Stock | SSaleDisposed | −511 | $74.94F4 | −$38,294.34 | 316,018 | Direct | |
| Sep 15, 2021 | Common Stock | SSaleDisposed | −264 | $73.69F6 | −$19,454.16 | 137,864 | Indirect | |
| Sep 15, 2021 | Common Stock | SSaleDisposed | −1,403 | $74.52F8 | −$104,551.56 | 136,461 | Indirect | |
| Sep 15, 2021 | Common Stock | SSaleDisposed | −263 | $73.69F6 | −$19,380.47 | 160,704 | Indirect | |
| Sep 15, 2021 | Common Stock | SSaleDisposed | −1,404 | $74.52F8 | −$104,626.08 | 159,300 | Indirect | |
| Sep 15, 2021 | Common Stock | SSaleDisposed | −263 | $73.69F6 | −$19,380.47 | 148,102 | Indirect | |
| Sep 15, 2021 | Common Stock | SSaleDisposed | −1,403 | $74.52F8 | −$104,551.56 | 146,699 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $72.860 to $73.830, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $73.870 to $74.860, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $74.880 to $75.015, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F6
This transaction was executed in multiple trades at prices ranging from $73.070 to $73.930, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 3 transactions in Table I.
- F8
This transaction was executed in multiple trades at prices ranging from $74.145 to $75.015, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 3 transactions in Table I.